Cargando…
VirB10 vaccination for protection against Anaplasma phagocytophilum
BACKGROUND: Human granulocytic anaplasmosis (HGA) is a tick-borne disease caused by the etiologic agent Anaplasma phagocytophilum. HGA was designated a nationally notifiable disease in the United States in 1998. Currently there are no vaccines available against HGA. Conserved membrane proteins that...
Autores principales: | Crosby, Francy L., Lundgren, Anna M., Hoffman, Carol, Pascual, David W., Barbet, Anthony F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299599/ https://www.ncbi.nlm.nih.gov/pubmed/30563470 http://dx.doi.org/10.1186/s12866-018-1346-x |
Ejemplares similares
-
Disruption of VirB6 Paralogs in Anaplasma phagocytophilum Attenuates Its Growth
por: Crosby, Francy L., et al.
Publicado: (2020) -
Immunogenicity of Outer Membrane Proteins VirB9-1 and VirB9-2, a Novel Nanovaccine against Anaplasma marginale
por: Zhao, Liang, et al.
Publicado: (2016) -
Nanoparticle-Based Delivery of Anaplasma marginale Membrane Proteins; VirB9-1 and VirB10 Produced in the Pichia pastoris Expression System
por: Zhang, Bing, et al.
Publicado: (2016) -
Interaction via the N terminus of the type IV secretion system (T4SS) protein VirB6 with VirB10 is required for VirB2 and VirB5 incorporation into T-pili and for T4SS function
por: Mary, Charline, et al.
Publicado: (2018) -
Immunogenic Response of Brucella canis
virB10 and virB11 Mutants in a Murine Model
por: Palomares-Resendiz, E., et al.
Publicado: (2012)